Cellsonics

Next Generation Single Cell Isolation

About

The Cellsonics platform was developed to build a novel approach to tissue disassociation using bulk lateral ultrasonic (BLU) vibrations to create precise shear stress patterns within tissue solutions, gently separating cells mechanically vs use of harsh digestive enzymes. The BLU technique improves sample fidelity and reduces genomic and biochemical changes within samples during this sample prep step.

  • Location: San Jose, CA
  • Paladin Initial Investment Date: August 2021

Portfolio Stats

Over 75 Companies

Paladin has invested in over 75 portfolio companies since 2001.

4 Continents

Paladin has invested in companies in North America, Australia, Europe, and South America.

Over $2 billion

Paladin was founded in 2001 and has since managed over $2B of companies and assets.